New Glass Vial Factory Boosts U. S. Vaccine Supply
A Global Leader Expands Its Capacity to Meet Critical Demand
In a move set to reshape the pharmaceutical supply chain, a German-owned facility in Lebanon County, Pennsylvania, has completed a $60 million expansion, tripling its production of glass vials used in life-saving medications.
The upgraded plant, operated by Schott Pharma, now features two advanced production lines capable of manufacturing both standard and sterile ready-to-use vials—containers essential for everything from vaccines to complex injectable drugs used in hospitals.
Cutting-Edge Technology & Domestic Manufacturing
The expansion includes:
- State-of-the-art converting machines for borosilicate glass, known for its strength and chemical stability.
- Modernized infrastructure and cutting-edge technology to ensure seamless operations.
- $38 million in federal funding from a health agency supporting advanced research—a clear sign of the government’s commitment to domestic production of critical drug packaging.
Everic Pure Vials: Precision for Global Health
The Pennsylvania site is now one of only two worldwide where Schott produces Everic pure vials—a premium product prized for its durability and precise dimensions, ensuring long-term drug stability.
With growing demand for high-quality pharmaceutical packaging, this expansion positions the U.S. as a key player in securing the supply of essential medications.
A Boost for Local Jobs & Economic Growth
The project has already delivered more than 200 new jobs to Lebanon County, reinforcing the region’s role as a pharmaceutical manufacturing hub.
State leaders, including the governor and the Department of Community Development, celebrated the opening with a ribbon-cutting ceremony, highlighting the facility’s role in strengthening the local economy.
A Legacy of Supporting National Health Crises
The Lebanon County plant has played a pivotal role in past health emergencies, supplying glass vials for 75% of federally supported COVID-19 vaccine projects during the pandemic.
Now, with its expanded capacity and advanced technology, the facility is better equipped to meet future medical needs—ensuring that patients worldwide continue to receive critical treatments without delay.
A Strategic Location in the Heart of Pharmaceutical Manufacturing
Situated on Lebanon Valley Parkway in South Lebanon Township, this facility has become a cornerstone of the region’s pharmaceutical sector, reinforcing Pennsylvania’s position as a leader in domestic medical manufacturing.
The expansion marks a significant step toward reducing reliance on foreign supply chains while enhancing the resilience of the U.S. healthcare system.